These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16809653)

  • 1. Peritoneal dialysis: a primary care perspective.
    Saxena R; West C
    J Am Board Fam Med; 2006; 19(4):380-9. PubMed ID: 16809653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.
    Takatori Y; Akagi S; Sugiyama H; Inoue J; Kojo S; Morinaga H; Nakao K; Wada J; Makino H
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1337-44. PubMed ID: 21493740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients.
    Yoon HE; Chang YK; Shin SJ; Choi BS; Kim BS; Park CW; Song HC; Yoon SA; Jin DC; Kim YS
    J Korean Med Sci; 2014 Sep; 29(9):1217-25. PubMed ID: 25246739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Trio Trial - A Randomized Controlled Clinical Trial Evaluating the Effect of a Biocompatible Peritoneal Dialysis Solution on Residual Renal Function.
    Sikaneta T; Wu G; Abdolell M; Ng A; Mahdavi S; Svendrovski A; Tu T; Mercer T; Tong M; Oreopoulos D; Tam P
    Perit Dial Int; 2016 9-10; 36(5):526-32. PubMed ID: 27282852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on peritoneal dialysis solutions.
    García-López E; Lindholm B; Davies S
    Nat Rev Nephrol; 2012 Feb; 8(4):224-33. PubMed ID: 22349485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Icodextrin Solution on the Preservation of Residual Renal Function in Peritoneal Dialysis Patients: A Randomized Controlled Study.
    Chang TI; Ryu DR; Yoo TH; Kim HJ; Kang EW; Kim H; Chang JH; Kim DK; Moon SJ; Yoon SY; Han SH;
    Medicine (Baltimore); 2016 Mar; 95(13):e2991. PubMed ID: 27043667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Residual Renal Function Decline in Peritoneal Dialysis Patients: The
    Htay H; Cho Y; Pascoe EM; Darssan D; Hawley C; Johnson DW;
    Perit Dial Int; 2017; 37(3):283-289. PubMed ID: 27935537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination of biocompatible peritoneal dialysis solutions and residual renal function, peritoneal transport, and inflammation markers: a randomized clinical trial.
    Lui SL; Yung S; Yim A; Wong KM; Tong KL; Wong KS; Li CS; Au TC; Lo WK; Ho YW; Ng F; Tang C; Chan TM
    Am J Kidney Dis; 2012 Dec; 60(6):966-75. PubMed ID: 22835900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical considerations when prescribing icodextrin: a narrative review.
    Silver SA; Harel Z; Perl J
    Am J Nephrol; 2014; 39(6):515-27. PubMed ID: 24925229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of icodextrin on patient survival and technique success in patients undergoing peritoneal dialysis.
    Han SH; Ahn SV; Yun JY; Tranaeus A; Han DS
    Nephrol Dial Transplant; 2012 May; 27(5):2044-50. PubMed ID: 21968011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Icodextrin: a review of its use in peritoneal dialysis.
    Frampton JE; Plosker GL
    Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Icodextrin-induced acute pancreatitis in a peritoneal dialysis patient: a case report and literature review
.
    Rubinstein S; Franjul R; Surana S; Fogel J
    Clin Nephrol; 2016 Nov; 86 (2016)(11):283-286. PubMed ID: 27616762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Icodextrin decreases technique failure and improves patient survival in peritoneal dialysis patients.
    Wang IK; Li YF; Chen JH; Liang CC; Liu YL; Lin HH; Chang CT; Tsai WC; Yen TH; Huang CC
    Nephrology (Carlton); 2015 Mar; 20(3):161-7. PubMed ID: 25487756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icodextrin and peritoneal dialysis: advantages and new applications.
    Dousdampanis P; Musso CG; Trigka K
    Int Urol Nephrol; 2018 Mar; 50(3):495-500. PubMed ID: 28674854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of and Fatality from Acute Pancreatitis in Long-Term Hemodialysis and Peritoneal Dialysis Patients.
    Wang IK; Lai SW; Lai HC; Lin CL; Yen TH; Chou CY; Chang CT; Huang CC; Sung FC
    Perit Dial Int; 2018; 38(1):30-36. PubMed ID: 29097488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peritoneal-renal syndrome.
    Nessim SJ; Bargman JM
    Nat Rev Nephrol; 2013 May; 9(5):302-6. PubMed ID: 23507827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatible dialysis fluids for peritoneal dialysis.
    Cho Y; Johnson DW; Craig JC; Strippoli GF; Badve SV; Wiggins KJ
    Cochrane Database Syst Rev; 2014 Mar; (3):CD007554. PubMed ID: 24671928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low GDP Solution and Glucose-Sparing Strategies for Peritoneal Dialysis.
    Szeto CC; Johnson DW
    Semin Nephrol; 2017 Jan; 37(1):30-42. PubMed ID: 28153193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel "bimodal" use of icodextrin peritoneal dialysis solutions.
    Burkart J
    Kidney Int; 1998 Apr; 53(4):1089-90. PubMed ID: 9551423
    [No Abstract]   [Full Text] [Related]  

  • 20. Determination of alpha-amylase activity in serum and dialysate from patients using icodextrin-based peritoneal dialysis fluid.
    Anderstam B; García-López E; Heimbürger O; Lindholm B
    Perit Dial Int; 2003; 23(2):146-50. PubMed ID: 12713081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.